Cardioprotection of salidroside from ischemia/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins - PubMed (original) (raw)
. 2009 Jun 24;613(1-3):93-9.
doi: 10.1016/j.ejphar.2009.04.012. Epub 2009 Apr 17.
Affiliations
- PMID: 19376110
- DOI: 10.1016/j.ejphar.2009.04.012
Cardioprotection of salidroside from ischemia/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins
Tiejun Wu et al. Eur J Pharmacol. 2009.
Abstract
The modification of proteins with O-linked N-acetylglucosamine (O-GlcNAc) is increasingly recognized as an important posttranslational modification that modulates cellular function. Recent studies suggested that augmentation of O-GlcNAc levels increase cell survival following stress. Salidroside, one of the active components of Rhodiola rosea, shows potent anti-hypoxia property. In the present study, we reported the cardioprotection of salidroside from ischemia and reperfusion. Cardiomyocytes were exposed to 4 h of ischemia and 16 h of reperfusion, and then cell viability, apoptosis, glucose uptake, ATP levels and cytosolic Ca(2+) concentration were determined, and O-GlcNAc levels were assessed by Western blotting. Salidroside (80 uM) was added 24 h before ischemia/reperfusion was induced. Treatment with salidroside markedly improved cell viability from 64.7+/-4.5% to 85.8+/-3.1%, decreased lactate dehydrogenase (LDH) release from 38.5+/-2.1% to 21.2+/-1.7%, reduced cell apoptosis from 27.2+/-3.2% to 12.2+/-1.9%, significantly improved cardiomyocytes glucose uptake by 1.7-fold and increased O-GlcNAc levels by 1.6-fold, as well as reducing cytosolic Ca(2+) concentration compared to untreated cells following ischemia/reperfusion. Furthermore, the improved cell survival and the increase in O-GlcNAc with salidroside were attenuated by alloxan, an inhibitor of O-GlcNAc transferase. These results suggested that salidroside significantly enhances glucose uptake and increases protein O-GlcNAc levels and this is associated with decreased cardiomyocytes injury following ischemia/reperfusion.
Similar articles
- Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc.
Champattanachai V, Marchase RB, Chatham JC. Champattanachai V, et al. Am J Physiol Cell Physiol. 2007 Jan;292(1):C178-87. doi: 10.1152/ajpcell.00162.2006. Epub 2006 Aug 9. Am J Physiol Cell Physiol. 2007. PMID: 16899550 - Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.
Liu J, Marchase RB, Chatham JC. Liu J, et al. J Mol Cell Cardiol. 2007 Jan;42(1):177-85. doi: 10.1016/j.yjmcc.2006.09.015. Epub 2006 Oct 27. J Mol Cell Cardiol. 2007. PMID: 17069847 Free PMC article. - Salidroside mitigates hypoxia/reoxygenation injury by alleviating endoplasmic reticulum stress‑induced apoptosis in H9c2 cardiomyocytes.
Sun MY, Ma DS, Zhao S, Wang L, Ma CY, Bai Y. Sun MY, et al. Mol Med Rep. 2018 Oct;18(4):3760-3768. doi: 10.3892/mmr.2018.9403. Epub 2018 Aug 20. Mol Med Rep. 2018. PMID: 30132527 Free PMC article. Retracted. - The Role of O-GlcNAcylation for Protection against Ischemia-Reperfusion Injury.
Jensen RV, Andreadou I, Hausenloy DJ, Bøtker HE. Jensen RV, et al. Int J Mol Sci. 2019 Jan 18;20(2):404. doi: 10.3390/ijms20020404. Int J Mol Sci. 2019. PMID: 30669312 Free PMC article. Review. - The role of protein O-linked beta-N-acetylglucosamine in mediating cardiac stress responses.
Chatham JC, Marchase RB. Chatham JC, et al. Biochim Biophys Acta. 2010 Feb;1800(2):57-66. doi: 10.1016/j.bbagen.2009.07.004. Epub 2009 Jul 14. Biochim Biophys Acta. 2010. PMID: 19607882 Free PMC article. Review.
Cited by
- Time-dependent effects of late-onset dietary intake of salidroside on lifespan and age-related biomarkers of the annual fish Nothobranchius guentheri.
Wang X, Du X, Zhou Y, Wang S, Su F, Zhang S. Wang X, et al. Oncotarget. 2018 Jan 4;9(19):14882-14894. doi: 10.18632/oncotarget.23957. eCollection 2018 Mar 13. Oncotarget. 2018. PMID: 29599913 Free PMC article. - The dual role of the hexosamine biosynthetic pathway in cardiac physiology and pathophysiology.
Cairns M, Joseph D, Essop MF. Cairns M, et al. Front Endocrinol (Lausanne). 2022 Oct 24;13:984342. doi: 10.3389/fendo.2022.984342. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36353238 Free PMC article. Review. - The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
Zachara NE. Zachara NE. Am J Physiol Heart Circ Physiol. 2012 May 15;302(10):H1905-18. doi: 10.1152/ajpheart.00445.2011. Epub 2012 Jan 27. Am J Physiol Heart Circ Physiol. 2012. PMID: 22287582 Free PMC article. Review. - Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.
Darley-Usmar VM, Ball LE, Chatham JC. Darley-Usmar VM, et al. J Mol Cell Cardiol. 2012 Mar;52(3):538-49. doi: 10.1016/j.yjmcc.2011.08.009. Epub 2011 Aug 22. J Mol Cell Cardiol. 2012. PMID: 21878340 Free PMC article. Review. - Rho, a Fraction From Rhodiola crenulate, Ameliorates Hepatic Steatosis in Mice Models.
Yi Q, Sun P, Li J, Kong S, Tian J, Li X, Yang Y, Zhang P, Liu Y, Han J, Zhang X, Ye F. Yi Q, et al. Front Physiol. 2018 Mar 14;9:222. doi: 10.3389/fphys.2018.00222. eCollection 2018. Front Physiol. 2018. PMID: 29593573 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous